Featured Content |VIEW MORE
News
An internationally renowned research scientist at the Phoenix Children’s Research Institute at the University of Arizona College of Medicine – Phoenix has been awarded a multimillion-dollar grant from the National Institutes of Health ...
Symposium
2023 Perspectives in Bronchopulmonary Dysplasia – Pharmacology of BPD
In September 2023, Phoenix Children’s Center for Fetal and Neonatal Care hosted its annual Bronchopulmonary Dysplasia (BPD) Conference.
Video
Patient and Family Perspective of Care – Assessing the Impact of Our Care
Dr. Deborah Tom moderated a panel discussion among parents of infants with BPD to explore how providers can better assess the needs of individual families and work within care teams to improve care delivery.
Video
Neuro-Sedative Use in the Inpatient Setting
Pharmacist Rhonda Kurz spoke on the variability in use of medications for BPD and variability of individual responses to medications.
Video
Emerging Therapies for Prevention and Treatment of BPD
Dr. Vlad Kalinichenko considered the use of novel pharmacologic treatments that may prevent BPD and/or more effectively treat the manifestations of BPD.
Video
Systemic Corticosteroids – Timing is Everything
Dr. Amy Brown presented on how the timing of use of systemic corticosteroids may prevent BPD and/or more effectively treat the manifestations of BPD.
Video
Challenges of Pharmacologic Management of BPD and Research Highlights Relating to Diuretic Usage
Dr. Nicolas Bamat, assistant professor of Pediatrics in the Division of Neonatology & Center for Clinical Effectiveness at Children’s Hospital of Philadelphia, was the keynote speaker, exploring the evolution of pharmacologic management ...
Video
Therapies for BPD-Associated Pulmonary Hypertension – What Do We Know Now?
Dr. Kevin Engelhardt presented on therapy options for BPD-associated pulmonary hypertension.
Video
Inhaled Respiratory Medications - “Helpful, Harmful, or Just a Burden?”
Dr. Rajeev Bhatia assessed the risks and benefits of commonly used medications for infants with BPD, as well as at the individual level for the specific patient.
